Literature DB >> 16474104

Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched.

M Pinzani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16474104      PMCID： PMC1856074          DOI： 10.1136/gut.2005.068585

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  27 in total

1.  Assessment of hepatic perfusion parameters with dynamic MRI.

Authors:  R Materne; A M Smith; F Peeters; J P Dehoux; A Keyeux; Y Horsmans; B E Van Beers
Journal:  Magn Reson Med       Date:  2002-01       Impact factor: 4.668

Review 2.  Fibrosis in chronic liver diseases: diagnosis and management.

Authors:  Massimo Pinzani; Krista Rombouts; Stefano Colagrande
Journal:  J Hepatol       Date:  2004-12-24       Impact factor: 25.083

3.  Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

Authors:  C Pilette; M C Rousselet; P Bedossa; D Chappard; F Oberti; H Rifflet; M Y Maïga; Y Gallois; P Calès
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

4.  Clinical significance of serum hyaluronan in patients with chronic viral liver disease.

Authors:  Y Murawaki; Y Ikuta; M Koda; Y Nishimura; H Kawasaki
Journal:  J Gastroenterol Hepatol       Date:  1996-05       Impact factor: 4.029

5.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

6.  Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

Authors:  Keyur Patel; Stuart C Gordon; Ira Jacobson; Christophe Hézode; Esther Oh; Katie M Smith; Jean-Michel Pawlotsky; John G McHutchison
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

7.  Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Authors:  Carolin Lackner; Gerd Struber; Bernadette Liegl; Sebastian Leibl; Petra Ofner; Csilla Bankuti; Bernd Bauer; Rudolf E Stauber
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

8.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

9.  Serum markers detect the presence of liver fibrosis: a cohort study.

Authors:  William M C Rosenberg; Michael Voelker; Robert Thiel; Michael Becka; Alastair Burt; Detlef Schuppan; Stefan Hubscher; Tania Roskams; Massimo Pinzani; Michael J P Arthur
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

10.  Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.

Authors:  J Guéchot; A Laudat; A Loria; L Serfaty; R Poupon; J Giboudeau
Journal:  Clin Chem       Date:  1996-04       Impact factor: 8.327
View more
  9 in total

1.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.

Authors:  Mirella Fraquelli; Cristina Rigamonti; Giovanni Casazza; Dario Conte; Maria Francesca Donato; Guido Ronchi; Massimo Colombo
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

Review 2.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

Review 3.  Recent advances in the pathogenesis and diagnosis of liver fibrosis.

Authors:  Natalie J Török
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

4.  A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C.

Authors:  G Shiha; S Seif; A Eldesoky; M Elbasiony; R Soliman; A Metwally; K Zalata; N Mikhail
Journal:  Hepatol Int       Date:  2017-04-19       Impact factor: 6.047

5.  Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Authors:  Shawky Abdelhamid Fouad; Serag Esmat; Dalia Omran; Laila Rashid; Mohamed H Kobaisi
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 6.  Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.

Authors:  Horia Stefanescu; Bogdan Procopet
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.

Authors:  Josh J Carlson; Kris V Kowdley; Sean D Sullivan; Scott D Ramsey; David L Veenstra
Journal:  J Gastroenterol Hepatol       Date:  2009-04-23       Impact factor: 4.029

8.  Non-invasive serum fibrosis markers: A study in chronic hepatitis.

Authors:  Mohammadreza Abdollahi; Aliasghar Pouri; Morteza Ghojazadeh; Rasoul Estakhri; Mohammadhossein Somi
Journal:  Bioimpacts       Date:  2015-02-22

9.  Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population.

Authors:  Kailash Marotrao Kolhe; Anjali Amarapurkar; Pathik Parikh; Alisha Chaubal; Shamsher Chauhan; Harshad Khairnar; Swapnil Walke; Meghraj Ingle; Vikas Pandey; Akash Shukla
Journal:  BMJ Open Gastroenterol       Date:  2019-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.